N-Methyl-D-glucamine
Spezifikationen
6284-40-8CAS-Nummer
228-506-9EG-Nummer
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentolIUPAC-Name
C7H17NO5Chemische Formel
195.21 g/molMolekulargewicht
meglumine; N-Methyl-D-glucamine; 6284-40-8; N-Methylsorbitylamine; D-Glucitol, 1-deoxy-1-(methylamino)-; Megluminum; 1-Deoxy-1-methylaminosorbitol; Methylglucamine; N-Methyl-D(-)-glucamine; d(-)-n-methylglucamine; 1-deoxy-1-methylamino-d-glucitol; 6HG8UB2MUY; D-(-)-N-Methylglucamine; NSC-7391; NSC-52907; CHEBI:59732; NSC52907; NSC7391; antimoniate de mAglumine; RefChem:389110; GlyTouCan:G20950LN; P01CB01; G20950LN; 228-506-9; N-Methylglucamine; Meglumin; 1-Deoxy-1-(methylamino)-D-glucitol; Meglumina; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; (2R,3R,4R,5S)-6-(Methylamino)hexane-1,2,3,4,5-pentaol; C7H17NO5; Sorbitol, 1-deoxy-1-methylamino-; MFCD00004707; DTXSID0023244; NSC 7391; NSC 52907; Megluminum [INN-Latin]; Meglumina [INN-Spanish]; Glucitol, 1-deoxy-1-(methylamino)-, D-; DTXCID503244; UNII-6HG8UB2MUY; EINECS 228-506-9; Meglumine CRS; Meglumine [USP:INN:BAN:JAN]; 1-Methylamino-1-deoxy-D-glucitol; N-methyl-glucamine; N-Methyl glucamine; NCGC00166125-01; CAS-6284-40-8; n-methyl-d glucamine; Meglumine (Standard); Meglumine (Excipient); MEGLUMINE [INN]; MEGLUMINE [JAN]; Fosaprepitant Impurity H; MEGLUMINE [II]; MEGLUMINE [VANDF]; MEGLUMINE [MART.]; EC 228-506-9; MEGLUMINE [USP-RS]; MEGLUMINE [WHO-DD]; MEGLUMINE [WHO-IP]; SCHEMBL2193; BIDD:GT0676; Meglumine (JP17/USP/INN); N-METHYLGLUCAMINE [MI]; orb1224417; orb1310549; SCHEMBL3530506; MEGLUMINE [ORANGE BOOK]; CHEMBL1200570; MEGLUMINE [EP MONOGRAPH]; HY-B0342A; HY-B0342R; (2R,3R,4R,5S)-6-Methylaminohexane-1,2,3,4,5-pentaol; MEGLUMINE [USP MONOGRAPH]; MEGLUMINUM [WHO-IP LATIN]; 1-deoxy-1-(methylamino)-glucitol; HMS2089B05; HMS3714B10; Pharmakon1600-01300029; HY-B0342; Tox21_112330; Tox21_302037; EBC-26175; NSC759607; AKOS005167162; AKOS015850890; N-methyl-1-amino-1-deoxy-D-glucitol; Tox21_112330_1; AC-4692; CCG-220884; MM07027; NSC-759607; RP10191; Meglumine 100 microg/mL in Acetonitrile; NCGC00166125-02; NCGC00166125-06; NCGC00255365-01; AC-17087; AS-12002; SBI-0206683.P002; Meglumine, meets USP testing specifications; M0227; SW199350-2; D01796; AB00430469-03; AB00430469_05; EN300-2394659; F050328; Q288875; SR-05000001446; N-Methyl-D-Glucamine(Discontinued,SeeCPTD788384); N-Methyl-D-glucamine, 99.0-100.5% (titration); SR-05000001446-1; BRD-K28595280-001-01-1; BRD-K28595280-001-03-7; BRD-K28595280-001-04-5; BRD-K28595280-001-05-2; N-Methyl-D-glucamine, Vetec(TM) reagent grade, 99%; N-Methyl-D-glucamine, ReagentPlus(R), >=99.0% (T); Z1255485274; (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentaol; Meglumine, United States Pharmacopeia (USP) Reference Standard; N-methyl-(2 (S),3 (R),4 (R),5 (R),6-pentahydroxy-hexyl)-amine; Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material; N-Methyl-D-glucamine, European Pharmacopoeia (EP) Reference Standard; Surfactant, Contrast agent, Antiemetic, Antial ergic, Anti kala-azar, Anticancer, Anti-inflammatory, Anti-infectives; Monomeglumine (Meglumine)Synonyme
Produkte, die N-Methyl-D-glucamine enthalten
유니레이프리필드주사가스트로그라핀보노아이주(수출용)보노아이프리필드주(수출용)메가레이주사(수출용)메가레이주사(프리필드)(수출용)1.도타렘주 2.도타렘주프리필드시린지ビリスコピン点滴静注50ウログラフイン注60%／ウログラフイン注60%／ウログラフイン注76%ガストログラフイン経口・注腸用DelecitDelecit
Seite 1 von 3
Dienstleistungen rund um N-Methyl-D-glucamine
Unternehmen, die N-Methyl-D-glucamine verkaufen
동국
동국제약(주)Republic of Korea
ZY
Zhengzhou Yuanli Biological Technology Co., Ltd.ChinaHV
Hangzhou Verychem Science And Technology Co.Ltd.ChinaCX
Chongqing Xingcan Pharmaceutical Technology Co., Ltd.ChinaSR
Suzhou Ryway Biotech Co., LtdChinaBE
Brother Enterprises Holding Co., LtdChina대한
대한약품공업(주)Republic of KoreaSeite 1 von 2